Monday, April 27, 2026

MUC5B Variant Associated with Idiopathic Pulmonary Fibrosis Suggests Decreased Risk of All-Cause Mortality

By: Mitchell Riley, PhD

Postdoctoral Associate (Welsh Lab)

 

Noon – 1 pm

1459 PBDB